WSU-HN6 Cells
USD$1,250.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | WSU-HN6 is a human squamous cell carcinoma (SCC) cell line derived from a tumor of the upper aerodigestive tract, specifically from the base of the tongue. It is part of a comprehensive panel of head and neck squamous cell carcinoma (HNSCC) cell lines established to model the biology of these cancers. WSU-HN6 has been instrumental in characterizing molecular alterations common in HNSCC, particularly those involving cell cycle regulation and growth signaling pathways. This cell line exhibits elevated activity of cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6, consistent with the inactivation of the tumor suppressor p16INK4A. While many HNSCC cell lines show overexpression of cyclin D1, WSU-HN6 does not, suggesting alternate routes to CDK activation, such as kinase overexpression or loss of negative regulators. Additionally, WSU-HN6 expresses wild-type p53, yet displays deregulation of cell cycle control, implicating other molecular defects, including potential deficiencies in p21 function or regulation. Functionally, WSU-HN6 demonstrates elevated tyrosine phosphorylation, reflective of aberrant activation of growth-promoting receptor tyrosine kinases. Enhanced epidermal growth factor receptor (EGFR) activity has been documented in this cell line, though EGFR protein overexpression is modest compared to other cell lines in the same panel. The EGFR in WSU-HN6 remains responsive to ligand stimulation and is functionally intact. These features position WSU-HN6 as a valuable in vitro model for studying deregulated growth signaling and CDK pathway abnormalities in head and neck cancers. |
|---|---|
| Organism | Human |
| Tissue | Tongue |
| Disease | Squamous cell carcinoma |
| Synonyms | HN6, Wayne State University-Head and Neck 6 |
Characteristics
| Age | Age unspecified |
|---|---|
| Gender | Male |
| Growth properties | Adherent |
Regulatory Data
| Citation | WSU-HN6 (Cytion catalog number 305888) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_5516 |
Biomolecular Data
| Mutational profile | Mutation: TP53, Simple, p.His179Leu (c.536A>T), Unspecified |
|---|
Handling
| Culture Medium | DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305888-171025 | Certificate of Analysis | 05. Dec. 2025 | 305888 |